FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Börse Stuttgart 12:47:55 27/06/2024 am IST | ||
| 10.37 EUR | -0.58% |
|
| Current month | -13.73% | ||
| 1 month | -16.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 10.37 | -0.58% |
| 25/24/25 | 10.43 | -7.70% |
| 24/24/24 | 11.3 | +4.73% |
| 21/24/21 | 10.79 | +4.15% |
| 20/24/20 | 10.36 | +6.04% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 12:47 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG3DH1 |
| ISIN | DE000MG3DH10 |
| Date issued | 30/04/2024 |
| Strike | 115.3 $ |
| Maturity | Unlimited |
| Parity | 2.09 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.83 € |
|---|---|
| Lowest since issue | 9.77 € |
| Spread | 0.1 € |
| Spread % | 0.95% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.6
USD
Average target price
147
USD
Spread / Average Target
+6.06%
- Stock Market
- Certificates
- Certificat
